BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magro CM, Mulvey J, Kubiak J, Mikhail S, Suster D, Crowson AN, Laurence J, Nuovo G. Severe COVID-19: A multifaceted viral vasculopathy syndrome. Ann Diagn Pathol 2021;50:151645. [PMID: 33248385 DOI: 10.1016/j.anndiagpath.2020.151645] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Nampoothiri M. The Nervous system, COVID-19 and Cerebrovascular complications: A strange riddle of the time. Trends Cardiovasc Med 2022:S1050-1738(22)00068-8. [PMID: 35561998 DOI: 10.1016/j.tcm.2022.05.001] [Reference Citation Analysis]
2 Johri S, Goyal M, Jain S, Baranwal M, Kumar V, Upadhyay R. A novel machine learning‐based analytical framework for automatic detection of COVID ‐19 using chest X‐ray images. Int J Imaging Syst Technol 2021;31:1105-19. [DOI: 10.1002/ima.22613] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Karabulut Uzuncakmak S, Dirican E, Naldan M, Kesmez Can F, Halıcı Z. Investigation of CYP2E1 and Caspase-3 Gene Expressions in COVID-19 patients. Gene Reports 2022;26:101497. [DOI: 10.1016/j.genrep.2022.101497] [Reference Citation Analysis]
4 Dimbath E, Maddipati V, Stahl J, Sewell K, Domire Z, George S, Vahdati A. Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review. Life Sci 2021;274:119341. [PMID: 33716059 DOI: 10.1016/j.lfs.2021.119341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Gille-johnson P, Kessler I, Tehrani S. Impaired Microvascular Function in Patients With Critical COVID-19. Critical Care Explorations 2022;4:e0643. [DOI: 10.1097/cce.0000000000000643] [Reference Citation Analysis]
6 Hanson PJ, Liu-fei F, Lai C, Toma M, Mcmanus BM. COVID-19-positivity in a heart transplant recipient—antibody-mediated rejection or SARS-CoV-2-associated cardiac injury? Oxford Medical Case Reports 2022;2022:omab143. [DOI: 10.1093/omcr/omab143] [Reference Citation Analysis]
7 Vollmer O, Tacquard C, Dieudonné Y, Nespola B, Sattler L, Grunebaum L, Gies V, Radosavljevic M, Kaeuffer C, Hansmann Y, Weber JC, Martin T, Arnaud L, Morel O, Guffroy A, Collange O, Mertes PM, Korganow AS, Delabranche X, Poindron V. Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent. Autoimmun Rev 2021;20:102822. [PMID: 33872769 DOI: 10.1016/j.autrev.2021.102822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
8 Dinulos JE, Dinulos JG. Cutaneous coronavirus disease 2019 in children: a clinical primer for diagnosis and treatment. Curr Opin Pediatr 2021;33:691-703. [PMID: 34670262 DOI: 10.1097/MOP.0000000000001076] [Reference Citation Analysis]
9 Parra-Medina R, Herrera S, Mejia J. Systematic Review of Microthrombi in COVID-19 Autopsies. Acta Haematol 2021;144:476-83. [PMID: 33873184 DOI: 10.1159/000515104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
10 Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, Shafaati M, Abdoli A. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Int Immunopharmacol 2021;101:108232. [PMID: 34673335 DOI: 10.1016/j.intimp.2021.108232] [Reference Citation Analysis]
11 Nicosia RF, Ligresti G, Caporarello N, Akilesh S, Ribatti D. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury. Am J Pathol 2021;191:1374-84. [PMID: 34033751 DOI: 10.1016/j.ajpath.2021.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Stassi C, Mondello C, Baldino G, Cardia L, Asmundo A, Ventura Spagnolo E. An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. Int J Mol Sci 2021;22:12024. [PMID: 34769454 DOI: 10.3390/ijms222112024] [Reference Citation Analysis]
13 Ohno M, Sasaki M, Orba Y, Sekiya T, Masum MA, Ichii O, Sawamura T, Kakino A, Suzuki Y, Kida H, Sawa H, Shingai M. Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2. Viruses 2021;13:2137. [PMID: 34834944 DOI: 10.3390/v13112137] [Reference Citation Analysis]
14 Yamada S, Asakura H. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. IJMS 2022;23:3338. [DOI: 10.3390/ijms23063338] [Reference Citation Analysis]
15 Gawaz A, Guenova E. Microvascular Skin Manifestations Caused by COVID-19. Hamostaseologie 2021;41:387-96. [PMID: 34695855 DOI: 10.1055/a-1581-6899] [Reference Citation Analysis]
16 Fancello V, Fancello G, Hatzopoulos S, Bianchini C, Stomeo F, Pelucchi S, Ciorba A. Sensorineural Hearing Loss Post-COVID-19 Infection: An Update. Audiology Research 2022;12:307-15. [DOI: 10.3390/audiolres12030032] [Reference Citation Analysis]
17 McGonagle D, De Marco G, Bridgewood C. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection. J Autoimmun 2021;121:102662. [PMID: 34051613 DOI: 10.1016/j.jaut.2021.102662] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
18 Kluck GEG, Yoo JA, Sakarya EH, Trigatti BL. Good Cholesterol Gone Bad? HDL and COVID-19. Int J Mol Sci 2021;22:10182. [PMID: 34638523 DOI: 10.3390/ijms221910182] [Reference Citation Analysis]
19 Giryes S, Bragazzi NL, Bridgewood C, De Marco G, McGonagle D. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells. Semin Immunopathol 2022. [PMID: 35412072 DOI: 10.1007/s00281-022-00928-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
21 Gallman AE, Fassett MS. Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease. Dermatol Clin 2021;39:533-43. [PMID: 34556243 DOI: 10.1016/j.det.2021.05.008] [Reference Citation Analysis]
22 Zito Marino F, De Cristofaro T, Varriale M, Zannini G, Ronchi A, La Mantia E, Campobasso CP, De Micco F, Mascolo P, Municinò M, Municinò E, Vestini F, Pinto O, Moccia M, De Stefano N, Nappi O, Sementa C, Zotti G, Pianese L, Giordano C, Franco R. Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR. Virchows Arch 2022. [PMID: 35103846 DOI: 10.1007/s00428-021-03262-8] [Reference Citation Analysis]
23 Oba S, Hosoya T, Amamiya M, Mitsumura T, Kawata D, Sasaki H, Kamiya M, Yamamoto A, Ando T, Shimada S, Shirai T, Okamoto T, Tateishi T, Endo A, Aiboshi J, Nosaka N, Yamanouchi H, Ugawa T, Nagaoka E, Oi K, Tao S, Maejima Y, Tanaka Y, Tanimoto K, Takeuchi H, Tohda S, Hirakawa A, Sasano T, Arai H, Otomo Y, Miyazaki Y, Yasuda S. Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in Japan. Front Cardiovasc Med 2021;8:767074. [PMID: 34869681 DOI: 10.3389/fcvm.2021.767074] [Reference Citation Analysis]
24 Kal M, Winiarczyk M, Cieśla E, Płatkowska-adamska B, Walczyk A, Biskup M, Pabjan P, Głuszek S, Odrobina D, Mackiewicz J, Zarębska-michaluk D. Retinal Microvascular Changes in COVID-19 Bilateral Pneumonia Based on Optical Coherence Tomography Angiography. JCM 2022;11:3621. [DOI: 10.3390/jcm11133621] [Reference Citation Analysis]
25 Magro C, Nuovo G, Mulvey JJ, Laurence J, Harp J, Crowson AN. The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. Clinics in Dermatology 2021;39:934-65. [DOI: 10.1016/j.clindermatol.2021.07.001] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Int J Immunopathol Pharmacol 2021;35:20587384211048026. [PMID: 34569339 DOI: 10.1177/20587384211048026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bösmüller H, Matter M, Fend F, Tzankov A. The pulmonary pathology of COVID-19. Virchows Arch 2021;478:137-50. [PMID: 33604758 DOI: 10.1007/s00428-021-03053-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
28 Aloul KM, Nielsen JE, Defensor EB, Lin JS, Fortkort JA, Shamloo M, Cirillo JD, Gombart AF, Barron AE. Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Front Immunol 2022;13:880961. [DOI: 10.3389/fimmu.2022.880961] [Reference Citation Analysis]